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Background & objectives: The past decade has seen a rapid expansion of directly observed treatment,
short-course (DOTS) centers throughout India, under the guidance of the Revised National
Tuberculosis Control Programme (RNTCP). While expansion has been rapid and extensive, few
reports exist detailing individual DOTS centers’ experiences, their challenges, and their successes.
We present a brief report on the status of a DOTS center being run at a large tertiary care center
in northern India for almost four years (2001-2005).
Methods: The DOTS center followed RNTCP guidelines for the evaluation and treatment of
suspected TB cases. A register carrying detailed information of all patients seen at the DOTS
center was kept by the senior clinician. Data from this register were extracted and analyzed for
descriptive measures.
Results: A total of 1490 patients were evaluated. Of the 768 patients with cough, 27 per cent (211)
were found to be sputum positive for acid-fast bacilli (AFB). Among patients who were initiated on
anti-tuberculosis medications, cure was achieved in 92 per cent (71 of 77) of new sputum smear
positive patients; treatment completion was achieved in 91 per cent (91 of 100) of extrapulmonary
TB (EPTB) and 75 per cent (46 of 61) of sputum-negative pulmonary TB patients. Overall treatment
success was achieved in 86 per cent (229 of 266).
Interpretation & conclusion: Treatment results were in keeping with the RNTCP guidelines. Tertiary
care centers appear to be excellent place for education of medical students and operational research.
The latter is much needed, as HIV-TB co-infection, multi-drug resistant TB, and EPTB continue
to be major public health threats even in the era of DOTS.
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Tuberculosis (TB) remains one of the top killers
in the developing world. This is especially true in
India, where each year approximately two million
new cases and 500,000 TB related deaths occur1. To
combat this overwhelming problem, the Government
of India piloted and then expanded a strategy of
directly observed treatment short-course (DOTS)
under the Revised National Tuberculosis Control
Programme (RNTCP)2. Piloted in 1993 and expanded
nationally in 1997, DOTS now covers over 1 billion
people, almost entire country3. Similar to the WHO-
endorsed DOTS strategy throughout the world, the
RNTCP aims at achieving 70 per cent case detection
rate through sputum microscopy and 85 per cent
treatment success rate amongst those who have been
detected. While many claims have been made about
the success of DOTS expansion in terms of numbers
covered3-10, there are only a few reports providing
details about actual treatment success rates11-13, the
problems associated with them14-17, and failures of
DOTS strategy18.
Here we report our experience of running a DOTS
center at All India Institute of Medical Sciences
(AIIMS), New Delhi, a large tertiary care teaching
hospital and research institution in northern India,
from December 2002 to August 2005. Initially, the
DOTS programme started as a pilot project that was
implemented under Employees Health Scheme (EHS)
for AIIMS employees and their dependents, a
population of 80,000. Following the publication of
the results11, some concerns were raised about the
less than optimal treatment success rate (80%), the
low rates of sputum microscopy (39%), and the low
yield of culture among smear-positive cases (55%).
These poor results at one of India’s top medical
centers were a cause of alarm for other DOTS centers
in the country, the bulk of which were in areas with
far fewer resources19.
Subsequent to the pilot project among AIIMS
employees and their dependents, the DOTS center
was expanded to cover all the patients in the
catchment area surrounding AIIMS. To address some
of the challenges and outcomes of the pilot study,
we carried out a retrospective analysis of the data
from this expanded project.
Material & Methods
Study population: Patients presented to the DOTS
center from a population of 100,000 living within a
4 km radius of AIIMS were included in the study.
This included a large number of AIIMS employees
and their dependents, as also people from the general
population.
Classification of cases: Patients were referred to the
DOTS center from various out-patient departments
of AIIMS, and from other public and private health
care providers in the area. RNTCP guidelines were
followed, and detailed methodology has been
presented in the previous report11. Briefly, all patients
with cough of three weeks or more (chest
symptomatics) submitted three separate sputum
samples (spot-morning-spot) for microscopy
examination. Patients with at least two positive
specimens for acid-fast bacilli (AFB) or one positive
AFB specimen with additional radiological features
suggestive of lung involvement were diagnosed to
have sputum smear-positive pulmonary tuberculosis
(PTB). Patients whose specimens were all negative
for AFB were given a trial of antibiotics for 1-2 wk
and if symptoms persisted were subjected to chest
radiographs. If chest radiograph findings were
suggestive of tuberculosis, the diagnosis of sputum
smear-negative PTB was made.
The diagnosis of extrapulmonary tuberculosis
(EPTB) was based on the following criteria: (i)
suggestive clinical features; (i i) positive
microbiological or histopathological evidence of
Mycobacterium tuberculosis from an extrapulmonary
site; (iii) radiographic changes suggestive of
tuberculosis; and (iv) a satisfactory response to anti-
tuberculosis therapy (ATT)11.
All diagnosed TB patients were divided in three
categories for therapeutic purposes1. During the
initial, intensive phase of treatment, patients were
given directly observed therapy three times a week.
The subsequent continuation phase consisted of a first
dose under direct supervision followed by a blister
pack of medicines for the rest of the week.  Patients
returned with the empty blister pack every subsequent
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week. Medicines were dispensed by the DOTS
provider at the DOTS center and home visits for
tracing of defaulters were made by DOTS team as
per RNTCP guidelines.
Data analysis: Patient data were extracted from the
registers maintained and kept at the DOTS center.
Data analyses for descriptive statistics were made
using SPSS version 10.0.
Results
A total of 1490 patients presented to DOTS center
during the study period. Of these, 768 (52%) patients
were chest symptomatic and they were subjected to
sputum microscopy for AFB. Of these, 211 (27%)
were found to be smear-positive. Another 557 (72%)
were found to be smear-negative TB. Another 722
of 1490 (48%) were found to have EPTB. Of the 100
patients with EPTB included in the study, 69 had
lymph node TB, 12 had osseous TB, 11 had TB
pleural effusion, three had disseminated TB, three
had abdominal TB and two had genital TB.
Being a tertiary care center many patients
belonged to different regions of the country; as per
RNTCP guidelines, such patients were referred to
DOTS center located in the area of patient’s
residence. As such, only 269 patients with TB had
treatment outcome documented at the AIIMS DOTS
center; another 3 patients were transferred during the
study period. As a result, only 266 patients were
available for analyses of treatment results (Table I).
Treatment success rate was highest for new (category
I) sputum positive PTB patients, with 71 of 77 (92%)
being documented cures. Treatment completion was
achieved in 91 per cent (91 of 100) of EPTB patients
and 88 per cent (92 of 105) of all sputum positive
PTB patients. Overall treatment success was noted
in 86 per cent (229 of 266) of patients (Table II).
Overall treatment success rate achieved was
higher for EHS cohort (88%) as compared to non-
EHS cohort (85%). For new sputum smear positive
PTB patients it was 100 per cent (25/25) for EHS
cohort. The EHS cohort also showed a lower default
rate (1.33%) as compared to non-EHS cohort (8.9%).
Some adverse drug reactions were also noticed
during the course of treatment. These included nausea
and vomiting in 30 (11%) and transient gastritis in
25 (9%) patients, which subsided following dietary
advice and measures aimed at reducing gastric
acid secretion. At the end of intensive phase of
Table II. Treatment outcome in 266 patients at DOTS center*
TB classification Number of patients
Cat-I† Cat-II† Cat-III† Failure Defaulter Died Total Treatment
Success (%)
Smear-positive 77 (71) 28 (21)   ____ 3 7 3 105 92 (88)
  pulmonary TB
Smear-negative 38 (30) 10 (8) 13(8) 5 6 4 61 46 (75)
  pulmonary TB
Extrapulmonary TB 55 (52) 14 (13) 31(26) 3 5 1 100 91 (91)
Total 170 (153) 52 (42) 44 (34) 11 18 8 266 229 (86)
*Only those patients who were not transferred due to location of residence; †Category and figures in parentheses denote no. of
patients who achieved treatment success for each group
Table I. Demographic characteristic of 266 patients at DOTS
center
Characteristic Number (%)
Median age (range) yr 25 (8-70)
Female 115 (43.2)
Male 151 (56.8)
AIIMS employee or dependent 75 (28.2)
Definite contact with TB+ 15 (5.6)
Other family members treated with DOTS 25 (9.4)
treatment, some abnormalities in laboratory tests
were also observed. These were as follows: elevated
serum aspartate aminotransferase or alanine
aminotransferase (>50 IU/l) in 9 (3%), elevated
serum alkaline phosphatase (>280 IU/l for adults and
>840 IU/l for children) in 2 (1%), elevated serum
uric acid (>7.4 mg/dl) in 8 (3%) and low platelet
counts (<1.5 lac/µl) were observed in 6 (2%) patients.
These patients did not have any clinical symptoms
or signs pertaining to the laboratory abnormalities
and were closely followed up during the continuation
phase of treatment without stopping ATT. These
patients did not develop any symptoms and signs
suggestive of overt adverse drug reaction and
laboratory abnormalities returned to normal at follow
up tests done after 1 month of continuation phase.
None of the patients developed any treatment limiting
adverse reactions.
Discussion
In this cohort of patients presenting to the AIIMS
DOTS center, excellent results were achieved at
follow up. This reinforces results of the previous
study, which suggested that tertiary care centers
should be the places where innovative TB control
programmes can be developed and monitored11. This
is especially true as much needed chemotherapeutic
and diagnostic technologies become available and
require evaluation before being made a part of the
national policy. For example, we are having
surveillance for multi drug resistant-TB (MDR-TB)
in category-II patients by subjecting them to sputum
culture and drug sensitivity testing so as to detect
MDR-TB cases early in these patients where chances
of MDR-TB is quite high as compared to fresh TB
cases20. Additionally, the DOTS center has provided
training for medical and nursing students and
residents in the care, prevention, and policy aspects
of TB control.
Treatment of EPTB was surprisingly effective.
This provides support to the argument that EPTB can
and should be more effectively addressed in the
national TB control programme. Currently, the focus
is on the more infectious smear-positive pulmonary
TB; however, as DOTS continues to expand, it has
become clear that the ultimate control of TB cannot
be achieved simply through treating pulmonary cases.
Our center did an excellent job managing the more
complicated regimens associated with EPTB; as there
were sufficient physical and human resources to
support this endeavor than are commonly found in
other Indian healthcare settings.  During this era of
growing HIV epidemic, EPTB becomes more
important as chances of developing EPTB in
immunocompromised patients are higher than their
immunocompetent counterparts21. It seems high time
that resources for EPTB are allocated to overcome
the diagnostic dilemma of varied clinical
presentation.
In conclusion, a powerful TB control programme
such as RNTCP is required to combat resurgence of
TB due to HIV infection. Involvement of medical
schools is vital for expansion of DOTS programme
as these are involved in the training of medical
students. Their importance also lies in the conducting
operational research, required to develop new tools
against fight of scourge of TB. The latter is especially
required for EPTB, MDR-TB and TB-HIV co-
infection.
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